ResMed Announces Participation in the 38th Annual J.P. Morgan Healthcare Conference
January 06 2020 - 9:00AM
Business Wire
ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell,
chief executive officer, will present at the 38th Annual J.P.
Morgan Annual Healthcare Conference on Monday, January 13, 2020,
beginning at approximately 8:30 a.m. (Pacific Standard Time) at
Westin St. Francis in San Francisco, CA.
More information about this event, including a live webcast, may
be accessed by visiting http://investor.resmed.com. The webcast
replay will be available approximately one hour after the live
webcast ends and will be accessible for approximately 90 days
following the conference.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions
that treat and keep people out of the hospital, empowering them to
live healthier, higher-quality lives. Our cloud-connected medical
devices transform care for people with sleep apnea, COPD, and other
chronic diseases. Our comprehensive out-of-hospital software
platforms support the professionals and caregivers who help people
stay healthy in the home or care setting of their choice. By
enabling better care, we improve quality of life, reduce the impact
of chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit ResMed.com
and follow @ResMed.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200106005001/en/
For investors Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
For media Jayme Rubenstein +1 858.836.6798
news@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024